Compound research
GHK-Cu: Research Overview & Current Status
GHK-Cu is a copper-binding tripeptide complex. Current research status: approved (non-drug / other indication). GHK-Cu is not an FDA-approved drug; it is used in cosmetic and dermatological products (an FDA-regulated category with different requirements than drugs) and has been evaluated in randomized clinical trials for topical skin applications, not systemic therapeutic indications.
Overview
GHK-Cu is a naturally occurring tripeptide (glycine-histidine-lysine) that binds copper(II) ions; it was first identified in human plasma in the 1970s and has since been studied for roles in wound healing, collagen/gene expression modulation, and skin biology. It is one of the most extensively studied peptides in cosmetic and regenerative research, with decades of published literature.
copper-binding tripeptide complex
Research timeline
1973
GHK tripeptide first identified in human plasma by Loren Pickart and colleagues.
Source →2006
Randomized clinical trial evaluated topical copper tripeptide complex on CO2 laser-resurfaced skin, comparing post-treatment regimens with and without GHK-Cu.
Source →2018
Review published on the skin regenerative and anti-cancer actions of copper peptides, summarizing gene-expression modulation research.
Source →2015
Study on microneedle-mediated delivery of GHK-Cu through skin, addressing the peptide's poor natural skin absorption due to hydrophilicity.
Source →
Active & recent research
Microneedle-Mediated Delivery of Copper Peptide Through Skin
using microneedle pre-treatment to enhance transdermal penetration of GHK-Cu
Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
post-laser-resurfacing erythema, wrinkle appearance, and patient-reported skin quality
Skin Regenerative and Anti-Cancer Actions of Copper Peptides
GHK-Cu's modulation of gene expression pathways relevant to skin repair and regeneration
Key findings
- A randomized trial on CO2 laser-resurfaced skin found topical GHK-Cu produced no statistically significant objective reduction in erythema or improvement in wrinkles versus controls, though patient-reported satisfaction was significantly higher in the GHK-Cu group.
- A 2018 review reported that GHK-Cu modulates expression of numerous genes associated with biochemical pathways relevant to skin repair and regeneration, and noted an established safety profile in topical cosmetic use.
- A 2015 study reported that microneedle pretreatment could safely and effectively enhance skin permeation of GHK-Cu, addressing its otherwise limited transdermal absorption due to hydrophilicity.
Safety & regulatory notes
GHK-Cu has a long history of topical cosmetic use and is generally described in the literature as having a favorable safety profile at the concentrations studied in skincare formulations; it is not FDA-approved as a drug and has not been evaluated for systemic/injectable use in large controlled human trials. As with any copper-containing compound, formulation, concentration, and route of administration materially affect safety, and injectable or research-chemical forms of GHK-Cu have not undergone the same regulatory review as approved cosmetic-ingredient uses.
We may earn a commission when readers buy through links on this page, at no extra cost to you. Commissions never affect a vendor's score — every vendor is graded on the same public rubric built from published lab documentation, live catalog pricing, and community sentiment. How we score →
Where it's sold for research
We track vendor availability and published pricing for GHK-Cu on a dedicated page. See where to buy GHK-Cu →
GHK-Cu FAQ
Is GHK-Cu FDA-approved?+
GHK-Cu is not approved by the FDA as a drug. It is used in cosmetic products, a category the FDA regulates differently from drugs, and has been studied in randomized trials for topical skin applications.
What is GHK-Cu studied for?+
Published research has examined GHK-Cu for topical skin effects including post-laser-resurfacing skin quality, gene-expression modulation relevant to wound healing and collagen regulation, and transdermal delivery methods.
Is GHK-Cu the same in injectable/research-chemical form as in skincare products?+
No. Most human clinical evidence relates to topical cosmetic formulations; injectable or research-chemical versions marketed separately have not been evaluated in the same controlled trials and carry different, less-established safety data.
Is GHK-Cu legal to buy for research purposes?+
Topical cosmetic formulations containing GHK-Cu are widely and legally sold as cosmetics; research-chemical (non-cosmetic) forms sold for laboratory use are labeled not for human consumption and are not reviewed by the FDA as drugs.
Sources for this page (4)
Related: all compound research overviews · research radar · full vendor rankings · methodology